RESUMO
Maternal severe zinc (Zn) deficiency resulted in growth retardation and high mortality during embryonic development in human. Therefore, this study is aimed at evaluating the effect of maternal marginal Zn deficiency on the development and redox status to avoid severe Zn deficiency using an avian model. A total of 324 laying duck breeders at 214 days old were randomly allotted into 3 dietary Zn levels with 6 replicates of 18 ducks per replicate. The birds were fed experimental diets including 3 dietary supplemental Zn levels of 0 mg/kg (maternal Zn-deficient group, 29.2 mg Zn/kg diet), 60 mg/kg (maternal Zn-adequate group), and 120 mg/kg (maternal Zn-high group) for 6 weeks. Dietary Zn levels had on effect on egg production and fertility (P > 0.05), whereas dietary Zn deficiency decreased breeder plasma Zn concentration and erythrocytic alkaline phosphatase activity at week 6 and inhibited erythrocytic 5'-nucleotidase (5'-NT) activity at weeks 2, 4, and 6 (P < 0.05), indicating that marginal Zn-deficient status occurred after Zn depletion. Maternal marginal Zn deficiency increased embryonic mortality and contents of superoxide anion radical, MDA, and PPC and reduced MT content and CuZnSOD activity in duck embryonic livers on E29. The MDA content was positively correlated with embryonic mortality. Maternal marginal Zn deficiency increased BCL2-associated X protein and Caspase-9 mRNA expressions as well as decreased B-cell lymphoma-2 and MT1 mRNA and signal AKT1 and ERK1 protein expressions (P < 0.05). Breeder plasma Zn concentration and erythrocytic 5'-NT activities at week 6 were positively correlated with GSH-Px activity and GPx, MT1, and BCL2 mRNA expressions in embryonic livers on E29. In conclusion, erythrocytic 5'-NT activity could be more rapid and reliable to monitor marginal Zn-deficient status. Marginal Zn deficiency impaired hatchability and antioxidant defense system and then induced oxidative damage and apoptosis in the embryonic liver, contributing to the greater loss of duck embryonic death.
Assuntos
Apoptose , Deficiências Nutricionais/metabolismo , Patos/embriologia , Embrião não Mamífero/metabolismo , Fenômenos Fisiológicos da Nutrição Materna , Estresse Oxidativo , Zinco/deficiência , 5'-Nucleotidase/sangue , Animais , Apoptose/genética , Proteínas Reguladoras de Apoptose/genética , Proteínas Reguladoras de Apoptose/metabolismo , Deficiências Nutricionais/genética , Deficiências Nutricionais/patologia , Deficiências Nutricionais/fisiopatologia , Modelos Animais de Doenças , Embrião não Mamífero/patologia , Eritrócitos/enzimologia , Feminino , Regulação da Expressão Gênica no Desenvolvimento , Fígado/embriologia , Fígado/enzimologia , Estado Nutricional , Oxirredução , Estresse Oxidativo/genéticaRESUMO
Dry skin is a common symptom of various conditions, and elderly individuals commonly exhibit this physiological symptom. Dry skin develops owing to sebum deficiency; however, the use of moisturizers can typically overcome this issue, particularly in patients in whom there are no other skin problems. If dry skin is left untreated, itching and eczema can occur, resulting in skin damage. Additionally, hemodialysis patients exhibit reduced barrier function and can experience pain associated with repeated needle insertion; the repeated use of lidocaine tape to manage the pain can cause further skin damage. To reduce the occurrence of dry skin, the skin is hydrated using moisturizers. Dry skin is also prominent in patients with varicose veins in the lower extremities, and many biochemical studies have shown that skin immunity is altered in patients with dry skin. Moreover, the incidences of dry skin and pruritus differ in male and female patients. Furthermore, in elderly patients, zinc deficiency is likely to cause dry skin, and zinc supplementation may maintain skin hydration. To date, few reports have described dry skin from a clinical point of view. In this review, research on dry skin is presented, and the findings of basic research studies are integrated.
Assuntos
Deficiências Nutricionais/tratamento farmacológico , Fármacos Dermatológicos/uso terapêutico , Dermatopatias/tratamento farmacológico , Pele/patologia , Varizes , Zinco/uso terapêutico , Fatores Etários , Animais , Deficiências Nutricionais/complicações , Deficiências Nutricionais/patologia , Suplementos Nutricionais , Eczema/etiologia , Eczema/prevenção & controle , Feminino , Humanos , Lidocaína , Masculino , Agulhas , Dor/etiologia , Prurido/etiologia , Prurido/prevenção & controle , Diálise Renal , Fatores Sexuais , Dermatopatias/etiologia , Dermatopatias/patologia , Zinco/deficiênciaRESUMO
Iron is the most common micronutrient deficiency in the world and it is most prevalent in young children, exposing their developing brain to inadequate iron levels. The damage related to neuroanatomical parameters is not reversed after iron treatment. However, evidence suggest that tactile stimulation (TS) may offer great therapeutic efficacy in cases of nutritional disorders postnatally, since the brain is remarkably responsive to its interaction with the environment. Recently, we shown that neonatal iron deficient rats achieved some remedial effect by exposing them to TS treatment early in life, reinforcing the fact that the TS approach is a positive enriching experience, therefore, here we ask whether exposure to TS treatment, could also be employed to prevent fine structural changes in the fibers from optic nerve of rats maintained on an iron-deficient diet during brain development. To elucidate the protective effect of tactile stimulation, our methods resulted in 10,859 analyzed fibers, divided into small and large fibers. We found that iron deficiency led to a decreased axon, fiber and myelin size of small fibers, however, TS completely reversed the iron-decifiency-induced alteration on those fiber measurements. Large fibers were disproportionately affected by iron deficiency and there was no remediating effect due to tactile stimulation treatment. The present study adds new information regarding different alterations between small and large fibers due to diet and TS, which suggest a size-based selectivity. These results emphasize the concept that compromised brain development can be mitigated at an early age by environmental factors, such as tactile stimulation.
Assuntos
Axônios/patologia , Deficiências Nutricionais/patologia , Deficiências Nutricionais/terapia , Manobra Psicológica , Deficiências de Ferro , Fibras Nervosas Mielinizadas/patologia , Nervo Óptico/patologia , Tato/fisiologia , Animais , Animais Recém-Nascidos , Modelos Animais de Doenças , Masculino , Estimulação Física , Ratos , Ratos WistarAssuntos
Cobre/deficiência , Derivação Gástrica/efeitos adversos , Doenças da Medula Espinal/diagnóstico por imagem , Oligoelementos/deficiência , Cobre/sangue , Cobre/uso terapêutico , Deficiências Nutricionais/patologia , Feminino , Humanos , Pessoa de Meia-Idade , Doenças da Medula Espinal/sangue , Doenças da Medula Espinal/terapia , Oligoelementos/sangue , Oligoelementos/uso terapêuticoRESUMO
Hepatic ammonia handling was analyzed in taurine transporter (TauT) KO mice. Surprisingly, hyperammonemia was present at an age of 3 and 12 months despite normal tissue integrity. This was accompanied by cerebral RNA oxidation. As shown in liver perfusion experiments, glutamine production from ammonia was diminished in TauT KO mice, whereas urea production was not affected. In livers from 3-month-old TauT KO mice protein expression and activity of glutamine synthetase (GS) were unaffected, whereas the ammonia-transporting RhBG protein was down-regulated by about 50%. Double reciprocal plot analysis of glutamine synthesis versus perivenous ammonia concentration revealed that TauT KO had no effect on the capacity of glutamine formation in 3-month-old mice, but doubled the ammonia concentration required for half-maximal glutamine synthesis. Since hepatic RhBG expression is restricted to GS-expressing hepatocytes, the findings suggest that an impaired ammonia transport into these cells impairs glutamine synthesis. In livers from 12-, but not 3-month-old TauT KO mice, RhBG expression was not affected, surrogate markers for oxidative stress were strongly up-regulated, and GS activity was decreased by 40% due to an inactivating tyrosine nitration. This was also reflected by kinetic analyses in perfused liver, which showed a decreased glutamine synthesizing capacity by 43% and a largely unaffected ammonia concentration dependence. It is concluded that TauT deficiency triggers hyperammonemia through impaired hepatic glutamine synthesis due to an impaired ammonia transport via RhBG at 3 months and a tyrosine nitration-dependent inactivation of GS in 12-month-old TauT KO mice.
Assuntos
Amônia/metabolismo , Deficiências Nutricionais , Inativação Metabólica , Fígado/metabolismo , Glicoproteínas de Membrana/metabolismo , Proteínas de Membrana Transportadoras/metabolismo , Animais , Deficiências Nutricionais/patologia , Modelos Animais de Doenças , Proteínas da Membrana Plasmática de Transporte de GABA/metabolismo , Técnicas de Silenciamento de Genes , Glutamato-Amônia Ligase/metabolismo , Glutamina/metabolismo , Glicoproteínas/metabolismo , Hepatócitos/metabolismo , Hiperamonemia/metabolismo , Cinética , Fígado/patologia , Glicoproteínas de Membrana/genética , Proteínas de Membrana Transportadoras/genética , Camundongos , Camundongos Knockout , Estresse Oxidativo , Perfusão , Ureia/metabolismoRESUMO
Meta-analytic evidence indicates that mood and psychotic disorders are associated with both omega-3 polyunsaturated fatty acid (omega-3 PUFA) deficits and progressive regional gray and white matter pathology. Although the association between omega-3 PUFA insufficiency and progressive neuropathological processes remains speculative, evidence from translational research suggests that omega-3 PUFA insufficiency may represent a plausible and modifiable risk factor not only for enduring neurodevelopmental abnormalities in brain structure and function, but also for increased vulnerability to neurodegenerative processes. Recent evidence from human neuroimaging studies suggests that lower omega-3 PUFA intake/status is associated with accelerated gray matter atrophy in healthy middle-aged and elderly adults, particularly in brain regions consistently implicated in mood and psychotic disorders, including the amygdala, anterior cingulate, hippocampus, prefrontal cortex, and temporal cortex. Human neuroimaging evidence also suggests that both low omega-3 PUFA intake/status and psychiatric disorders are associated with reductions in white matter microstructural integrity and increased rates of white matter hyperintensities. Preliminary evidence suggests that increasing omega-3 PUFA status is protective against gray matter atrophy and deficits in white matter microstructural integrity in patients with mood and psychotic disorders. Plausible mechanisms mediating this relationship include elevated pro-inflammatory signaling, increased synaptic regression, and reductions in cerebral perfusion. Together these associations encourage additional neuroimaging research to directly investigate whether increasing omega-3 PUFA status can mitigate neuropathological processes in patients with, or at high risk for, psychiatric disorders.
Assuntos
Deficiências Nutricionais , Ácidos Graxos Ômega-3 , Substância Cinzenta , Transtornos Mentais , Substância Branca , Animais , Deficiências Nutricionais/dietoterapia , Deficiências Nutricionais/patologia , Ácidos Graxos Ômega-3/administração & dosagem , Ácidos Graxos Ômega-3/deficiência , Substância Cinzenta/efeitos dos fármacos , Substância Cinzenta/metabolismo , Substância Cinzenta/patologia , Humanos , Transtornos Mentais/dietoterapia , Transtornos Mentais/metabolismo , Transtornos Mentais/patologia , Substância Branca/efeitos dos fármacos , Substância Branca/metabolismo , Substância Branca/patologiaRESUMO
The original article was published on July19, 2017 and corrected on May 15, 2018. The revised version of the article includes a funding source for Dr. Maija Kiuru's participation in this case report, awarded by the National Cancer Institute, National Institutes of Health grant K12CA138464. This change appears in the revised online PDF copy of this article.
Assuntos
Acrodermatite/patologia , Deficiências Nutricionais/patologia , Nutrição Parenteral Total/efeitos adversos , Pênfigo/diagnóstico , Dermatopatias Vesiculobolhosas/patologia , Zinco/deficiência , Acrodermatite/diagnóstico , Acrodermatite/etiologia , Idoso , Deficiências Nutricionais/diagnóstico , Deficiências Nutricionais/etiologia , Diagnóstico Diferencial , Feminino , Humanos , Dermatopatias Vesiculobolhosas/diagnóstico , Dermatopatias Vesiculobolhosas/etiologiaRESUMO
The first manifestations that appear under zinc deficiency are skin defects such as dermatitis, alopecia, acne, eczema, dry, and scaling skin. Several genetic disorders including acrodermatitis enteropathica (also known as Danbolt-Closs syndrome) and Brandt's syndrome are highly related to zinc deficiency. However, the zinc-related molecular mechanisms underlying normal skin development and homeostasis, as well as the mechanism by which disturbed zinc homeostasis causes such skin disorders, are unknown. Recent genomic approaches have revealed the physiological importance of zinc transporters in skin formation and clarified their functional impairment in cutaneous pathogenesis. In this review, we provide an overview of the relationships between zinc deficiency and skin disorders, focusing on the roles of zinc transporters in the skin. We also discuss therapeutic outlooks and advantages of controlling zinc levels via zinc transporters to prevent cutaneous disorganization.
Assuntos
Proteínas de Transporte de Cátions/metabolismo , Absorção Cutânea , Pele/metabolismo , Zinco/metabolismo , Animais , Proteínas de Transporte de Cátions/genética , Deficiências Nutricionais/genética , Deficiências Nutricionais/metabolismo , Deficiências Nutricionais/patologia , Homeostase , Humanos , Pele/patologia , Dermatopatias/genética , Dermatopatias/metabolismo , Dermatopatias/patologia , Zinco/deficiênciaRESUMO
PURPOSE: Zinc restriction during fetal and postnatal development could program cardiovascular diseases in adulthood. The aim of this study was to determine the effects of zinc restriction during fetal life, lactation, and/or post-weaning growth on cardiac inflammation, apoptosis, oxidative stress, and nitric oxide system of male and female adult rats. METHODS: Wistar rats were fed a low- or a control zinc diet during pregnancy and up to weaning. Afterward, offspring were fed either a low- or a control zinc diet until 81 days of life. IL-6 and TNF-α levels, TUNEL assay, TGF-ß1 expression, thiobarbituric acid-reactive substances that determine lipoperoxidation damage, NADPH oxidase-dependent superoxide anion production, antioxidant and nitric oxide synthase activity, mRNA and protein expression of endothelial nitric oxide synthase, and serine1177 phosphorylation isoform were determined in left ventricle. RESULTS: Zinc deficiency activated apoptotic and inflammatory processes and decreased TGF-ß1 expression and nitric oxide synthase activity in cardiac tissue of both sexes. Male zinc-deficient rats showed no changes in endothelial nitric oxide synthase expression, but a lower serine1177 phosphorylation. Zinc deficiency induced an increase in antioxidant enzymes activity and no differences in lipoperoxidation products levels in males. Females were less sensitive to this deficiency exhibiting lower increase in apoptosis, lower decrease in expression of TGF-ß1, and higher antioxidant and nitric oxide enzymes activities. A zinc-adequate diet during postnatal life reversed most of these mechanisms. CONCLUSION: Prenatal and postnatal zinc deficiency induces alterations in cardiac apoptotic, inflammatory, oxidative, and nitric oxide pathways that could predispose the onset of cardiovascular diseases in adult life.
Assuntos
Deficiências Nutricionais/fisiopatologia , Desenvolvimento Fetal , Lactação , Fenômenos Fisiológicos da Nutrição Materna , Miocardite/etiologia , Estresse Oxidativo , Zinco/deficiência , Animais , Apoptose , Biomarcadores/sangue , Biomarcadores/metabolismo , Vasos Coronários/imunologia , Vasos Coronários/metabolismo , Vasos Coronários/patologia , Vasos Coronários/fisiopatologia , Deficiências Nutricionais/imunologia , Deficiências Nutricionais/metabolismo , Deficiências Nutricionais/patologia , Endotélio Vascular/imunologia , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Endotélio Vascular/fisiopatologia , Feminino , Regulação Enzimológica da Expressão Gênica , Mediadores da Inflamação/sangue , Mediadores da Inflamação/metabolismo , Masculino , Miométrio/imunologia , Miométrio/metabolismo , Miométrio/patologia , Miométrio/fisiopatologia , Óxido Nítrico Sintase Tipo III/genética , Óxido Nítrico Sintase Tipo III/metabolismo , Gravidez , Distribuição Aleatória , Ratos Wistar , DesmameRESUMO
: In 2015, an emaciated Rocky Mountain bighorn ( Ovis canadensis) ram was submitted to the Utah Veterinary Diagnostic Laboratory for necropsy. There were numerous thick-walled abscesses subcutaneously and internally, and Corynebacterium pseudotuberculosis was isolated in pure culture. In addition, the ram was severely copper deficient, with a liver copper concentration of 1.6 mg/kg.
Assuntos
Cobre/deficiência , Infecções por Corynebacterium/veterinária , Corynebacterium pseudotuberculosis/isolamento & purificação , Deficiências Nutricionais/veterinária , Carneiro da Montanha , Animais , Infecções por Corynebacterium/epidemiologia , Infecções por Corynebacterium/microbiologia , Infecções por Corynebacterium/patologia , Deficiências Nutricionais/patologia , Masculino , Utah/epidemiologiaRESUMO
To evaluate the effects of dietary high molybdenum (HMo) and low copper (LCu) concentrations on reproductive toxicity of male mice, 80 mice were divided into 4 groups of 20. These groups were fed with the following: (1) normal control (NC) diet (NC group); (2) NC and HMo diets (HMo group); (3) LCu diet (LCu group); and (4) HMo and LCu diets (HMoLCu group). On the 50th and 100th day, superoxide dismutase (SOD), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), and total antioxidant capacity (T-AOC) were analyzed to determine oxidative stress states. Morphological changes in testicular tissue were evaluated with hematoxylin and eosin staining and ultrastructural changes were monitored by transmission electron microscopy. The results showed that administration of HMo, LCu, and HMoLCu not only decreased sperm density and motility but also increased the rate of teratosperm occurrence. A significant increase in MDA content and a decrease in SOD, GSH-Px, and T-AOC contents were observed in LCu, HMo, and HMoLCu groups. Testicular tissues and cells of mice were damaged by HMo and the damages were more serious in the case of Cu deficiency. Exposure to HMo adversely affected the reproductive system of male mice, and dietary LCu plays key roles in HMo-induced reproductive toxicity.
Assuntos
Cobre/deficiência , Deficiências Nutricionais/fisiopatologia , Dieta/efeitos adversos , Intoxicação por Metais Pesados , Infertilidade Masculina/etiologia , Molibdênio/intoxicação , Intoxicação/fisiopatologia , Testículo/ultraestrutura , Animais , Animais não Endogâmicos , Deficiências Nutricionais/etiologia , Deficiências Nutricionais/metabolismo , Deficiências Nutricionais/patologia , Peroxidação de Lipídeos , Masculino , Metais Pesados/metabolismo , Camundongos , Microscopia Eletrônica de Transmissão , Estresse Oxidativo , Oxirredutases/sangue , Oxirredutases/metabolismo , Intoxicação/etiologia , Intoxicação/metabolismo , Intoxicação/patologia , Motilidade dos Espermatozoides , Espermatogênese , Espermatozoides/enzimologia , Espermatozoides/metabolismo , Espermatozoides/ultraestrutura , Teratozoospermia/etiologia , Testículo/enzimologia , Testículo/metabolismo , Aumento de PesoRESUMO
The consequences of carnitine depletion upon metabolic and contractile characteristics of skeletal muscle remain largely unexplored. Therefore, we investigated the effect of N-trimethyl-hydrazine-3-propionate (THP) administration, a carnitine analog inhibiting carnitine biosynthesis and renal reabsorption of carnitine, on skeletal muscle function and energy metabolism. Male Sprague-Dawley rats were fed a standard rat chow in the absence (CON; n = 8) or presence of THP (n = 8) for 3 wk. Following treatment, rats were fasted for 24 h prior to excision of their soleus and EDL muscles for biochemical characterization at rest and following 5 min of contraction in vitro. THP treatment reduced the carnitine pool by â¼80% in both soleus and EDL muscles compared with CON. Carnitine depletion was associated with a 30% decrease soleus muscle weight, whereas contractile function (expressed per gram of muscle), free coenzyme A, and water content remained unaltered from CON. Muscle fiber distribution and fiber area remained unaffected, whereas markers of apoptosis were increased in soleus muscle of THP-treated rats. In EDL muscle, carnitine depletion was associated with reduced free coenzyme A availability (-25%, P < 0.05), impaired peak tension development (-44%, P < 0.05), and increased glycogen hydrolysis (52%, P < 0.05) during muscle contraction, whereas PDC activation, muscle weight, and water content remained unaltered from CON. In conclusion, myopathy associated with carnitine deficiency can have different causes. Although muscle atrophy, most likely due to increased apoptosis, is predominant in muscle composed predominantly of type I fibers (soleus), disturbance of energy metabolism appears to be the major cause in muscle composed of type II fibers (EDL).
Assuntos
Carnitina/deficiência , Deficiências Nutricionais/fisiopatologia , Modelos Animais de Doenças , Metabolismo Energético , Contração Muscular , Músculo Esquelético/fisiopatologia , Atrofia Muscular/etiologia , Animais , Apoptose , Biomarcadores/metabolismo , Carnitina/antagonistas & inibidores , Deficiências Nutricionais/induzido quimicamente , Deficiências Nutricionais/metabolismo , Deficiências Nutricionais/patologia , Glicogenólise , Masculino , Metilidrazinas , Desenvolvimento Muscular , Fibras Musculares de Contração Rápida/metabolismo , Fibras Musculares de Contração Rápida/patologia , Fibras Musculares de Contração Lenta/metabolismo , Fibras Musculares de Contração Lenta/patologia , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Distribuição Aleatória , Ratos Sprague-DawleyRESUMO
Keshan disease is an endemic dilated cardiomyopathy (DCM) which is closely related with selenium-deficient diet in China. In the previous study, we reported that the low selenium status plays a pivotal role in the myocardial apoptosis in the DCM rats, however, the underlying mechanism remains unclear. The present study aimed to determine whether the intrinsic, extrinsic pathways and the upstream regulators were involved in the myocardial apoptosis of selenium deficiency-induced DCM rats. Therefore, the rat model of endemic DCM was induced by a selenium-deficient diet for 12 weeks. Accompanied with significant dilation and impaired systolic function of left ventricle, an enhanced myocardial apoptosis was detected by TUNEL assay. Western blot analysis showed remarkably increased protein levels of cleaved caspase-3, caspase-8, caspase-9, and cytosolic cytochrome c released from the mitochondria. In addition, the immunoreactivities of p53 and Bax were significantly up-regulated, while the anti-apoptotic Bcl-2 family members Bcl-2 and Bcl-X(L) were down-regulated. Furthermore, appropriate selenium supplement for another 4 weeks could partially reverse all the above changes. In conclusion, the intrinsic, extrinsic pathways and the upstream regulators such as p53, Bax, Bcl-2, and Bcl-X(L )were all involved in selenium deficiency-induced myocardial apoptosis.
Assuntos
Proteínas Reguladoras de Apoptose/metabolismo , Apoptose , Cardiomiopatia Dilatada/etiologia , Caspases/metabolismo , Deficiências Nutricionais/fisiopatologia , Miocárdio/metabolismo , Selênio/deficiência , Animais , Cardiomiopatias/diagnóstico por imagem , Cardiomiopatias/etiologia , Cardiomiopatia Dilatada/diagnóstico por imagem , Caspase 3/química , Caspase 3/metabolismo , Caspase 8/química , Caspase 8/metabolismo , Caspase 9/química , Caspase 9/metabolismo , Caspases/química , Fragmentação do DNA , Deficiências Nutricionais/dietoterapia , Deficiências Nutricionais/metabolismo , Deficiências Nutricionais/patologia , Suplementos Nutricionais , Ecocardiografia , Infecções por Enterovirus/diagnóstico por imagem , Infecções por Enterovirus/etiologia , Coração/fisiopatologia , Miocárdio/enzimologia , Miocárdio/patologia , Fragmentos de Peptídeos/metabolismo , Processamento de Proteína Pós-Traducional , Proteólise , Distribuição Aleatória , Ratos Sprague-Dawley , Selênio/sangue , Selênio/uso terapêuticoRESUMO
Hepatic zinc deficiency has been well documented in alcoholic patients, but the mechanisms by which zinc deficiency mediates cell death have not been well defined. The objectives of this study were to determine whether alcohol perturbs subcellular zinc homeostasis and how organelle zinc depletion may link with cell death pathways. Wistar rats were pair-fed with the Lieber-DeCarli control or ethanol diet for 5 mo. Chronic alcohol exposure significantly reduced zinc level in isolated hepatic endoplasmic reticulum (ER) and mitochondria. Among the detected zinc transporters, ER Zrt/Irt-like protein (ZIP)13 and mitochondrial ZIP8, which transport zinc from ER and mitochondria to cytosol, were significantly increased. Mitochondrial zinc transporter (ZnT) 4, which transports zinc from cytosol to mitochondria, was also increased. ER phosphorylated eukaryotic initiation factor 2α, activating transcription factor 4, and C/EBP homologous protein were significantly upregulated, and mitochondrial cytochrome c release and Bax insertion were detected in association with caspase-3 activation and apoptotic cell death. To define the role of zinc deficiency in ER and mitochondrial stress, H4IIEC3 cells were treated with 3 µM N,N,N',N'-tetrakis (2-pyridylmethyl) ethylenediamine for 6 h with or without supplementation with zinc or N-acetylcysteine (NAC). The results demonstrated that zinc deprivation induced caspase-3 activation and apoptosis in association with ER and mitochondria dysfunction, which were inhibited by zinc as low as 10 µM but not by 2 mM NAC. These results suggest that chronic ethanol exposure induced in ER and mitochondrial zinc deficiency might activate intrinsic cell death signaling pathway, which could not be effectively rescued by antioxidant treatment.
Assuntos
Apoptose , Deficiências Nutricionais/etiologia , Retículo Endoplasmático/metabolismo , Etanol , Hepatopatias Alcoólicas/etiologia , Fígado/metabolismo , Mitocôndrias Hepáticas/metabolismo , Zinco/deficiência , Fator 4 Ativador da Transcrição/metabolismo , Animais , Antioxidantes/farmacologia , Apoptose/efeitos dos fármacos , Proteínas de Transporte/metabolismo , Caspase 3/metabolismo , Proteínas de Transporte de Cátions/metabolismo , Linhagem Celular Tumoral , Quelantes/farmacologia , Deficiências Nutricionais/sangue , Deficiências Nutricionais/patologia , Modelos Animais de Doenças , Retículo Endoplasmático/efeitos dos fármacos , Retículo Endoplasmático/patologia , Fator de Iniciação 2 em Eucariotos/metabolismo , Fígado/efeitos dos fármacos , Fígado/patologia , Hepatopatias Alcoólicas/sangue , Hepatopatias Alcoólicas/patologia , Masculino , Proteínas de Membrana Transportadoras , Mitocôndrias Hepáticas/efeitos dos fármacos , Mitocôndrias Hepáticas/patologia , Estresse Oxidativo , Fosforilação , Ratos Wistar , Espécies Reativas de Oxigênio/metabolismo , Fatores de Tempo , Fator de Transcrição CHOP/metabolismo , Zinco/sangueRESUMO
BACKGROUND: n. The study was aimed at determining, on an animal model, effects of supplementing a diet, modified by substituting whole wheat and corn grains with white flour and sucrose, with calcium, magnesium, zinc, and chromium on metabolism of the minerals and their distribution in the body. METHODS: The study involved 4 groups of Wistar rat females (n = 11) fed: a standard feed (group I) containing, i.a., whole wheat and corn grains; modified feed (84% and 50% of whole wheat and corn grains, respectively, in the standard feed substituted with Type 500 wheat flour and sucrose, respectively) (group II); modified feed with complementary supplementation (elimination of Ca, Mg, Zn, and Cr deficiencies resulting from diet modification) (group III); and modified feed with excess supplementation (the same minerals applied in excess, i.e., amounts from 0.5 to 3 times higher than the deficiencies produced by diet modification) (group IV). The replacement of whole grains with white flour and sucrose, as well as the mineral supplementation could, to some extent, imitate the contemporary eating habits and supplementation applied in food technology. The excess supplementation is, on the other hand, typical of current behaviours of various social groups. RESULTS: Both types of supplementation resulted in a significant increase in the perivisceral adipose tissue content, but did not affect the fat tissue content in muscles. The supplementation applied did not change the content of calcium, magnesium, and zinc in muscles, nor did it significantly change calcium and magnesium excretion with urine. However, changes in the ALP activity and calcitonin concentration did not suggest the deposition of the minerals in bones. CONCLUSIONS: Analysis of the results allowed to conclude that: 1) except for chromium, contents of the selected minerals in the tissues examined and urea, as well as concentrations of calcitonin and alkaline phosphatase (ALP) activities did not point to any significant effect of the supplementation applied on the body contents of those minerals; 2) effects observed as the accumulation of perivisceral, epicardial and intramuscular adipose tissue, as well as increased body weight increments could have been related to disturbed proportions of the minerals supplemented, their synergy and antagonism and, consequently, a potential generation of secondary deficiencies and excesses which could significantly affect individual metabolic pathways; 3) the intensity of changes observed was generally higher in the females receiving complementary supplementation, although their uptake of minerals studied was similar to that shown by the females kept on the standard diet.
Assuntos
Cálcio da Dieta/uso terapêutico , Cromo/uso terapêutico , Deficiências Nutricionais/prevenção & controle , Dieta Ocidental/efeitos adversos , Suplementos Nutricionais , Magnésio/uso terapêutico , Zinco/uso terapêutico , Adiposidade , Animais , Cálcio/sangue , Cálcio/metabolismo , Cálcio/urina , Cálcio da Dieta/administração & dosagem , Cálcio da Dieta/efeitos adversos , Cromo/administração & dosagem , Cromo/efeitos adversos , Cromo/metabolismo , Deficiências Nutricionais/etiologia , Deficiências Nutricionais/metabolismo , Deficiências Nutricionais/patologia , Suplementos Nutricionais/efeitos adversos , Ingestão de Energia , Feminino , Gordura Intra-Abdominal/crescimento & desenvolvimento , Gordura Intra-Abdominal/patologia , Magnésio/efeitos adversos , Magnésio/metabolismo , Magnésio/urina , Músculo Esquelético/crescimento & desenvolvimento , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Polônia , Ratos Wistar , Aumento de Peso , Zinco/administração & dosagem , Zinco/efeitos adversos , Zinco/metabolismoRESUMO
Zinc (Zn) regulates numerous cellular functions. Zn deficiency is common in females; â¼80% of women and 40% of adolescent girls consume inadequate Zn. Zn deficiency enhances oxidative stress, inflammation and DNA damage. Oxidative stress and inflammation is associated with breast disease. We hypothesized that Zn deficiency increases oxidative stress in the mammary gland, altering the microenvironment and architecture. Zn accumulated in the mammary glands of Zn deficient mice and this was associated with macrophage infiltration, enhanced oxidative stress and over-expression of estrogen receptor α. Ductal and stromal hypercellularity was associated with aberrant collagen deposition and disorganized e-cadherin. Importantly, these microenvironmental alterations were associated with substantial impairments in ductal expansion and mammary gland development. This is the first study to show that marginal Zn deficiency creates a toxic microenvironment in the mammary gland impairing breast development. These changes are consistent with hallmarks of potential increased risk for breast disease and cancer.
Assuntos
Deficiências Nutricionais/metabolismo , Dieta , Glândulas Mamárias Animais/metabolismo , Estresse Oxidativo , Zinco/metabolismo , Fatores Etários , Animais , Proteínas de Transporte de Cátions/metabolismo , Proliferação de Células , Microambiente Celular , Colágeno/metabolismo , Deficiências Nutricionais/complicações , Deficiências Nutricionais/patologia , Modelos Animais de Doenças , Receptor alfa de Estrogênio/metabolismo , Feminino , Humanos , Hiperplasia , Macrófagos/metabolismo , Glândulas Mamárias Animais/crescimento & desenvolvimento , Glândulas Mamárias Animais/patologia , Camundongos Endogâmicos C57BL , Medição de Risco , Zinco/toxicidadeRESUMO
A cirurgia bariátrica continua a ser o tratamento mais efetivo para obesidade mórbida e a mais associada a outras condições metabólicas tais como diabetes tipo 2, doença refluxo gastroesofágico, e apneia do sono obstrutiva. Na população obesa, deficiências nutricionais comuns incluem vitaminas A, C, D, e B12, folato, tiamina, ferro, ferritina, zinco e selênio. Com a perda de peso ponderal, muitos pacientes podem utilizar o contorno corporal para deformidades. Após perda de peso ponderal seguida de cirurgia bariátrica, os pacientes geralmente desenvolvem deficiência nutricional significante que aumenta o risco de morbidade e mortalidade pós-operatória com quaisquer cirurgias subsequentes. Alguns pacientes requererem avaliação adicional durante a doença, ou quando candidatos eletivos pré-cirurgia, devido a alterações no trato alimentar com objetivo de melhorar os resultados e prevenir complicações devido a deficiências nutricionais.
Bariatric surgery continues to be the most effective treatment for morbid obesity and most other associated metabolic conditions such as type 2 diabetes mellitus, gastroesophageal reflux disease, and obstructive sleep apnea. In the obese population, common nutritional deficiencies include vitamins A, C, D, and B12, folate, thiamine, iron, ferritin, zinc, and selenium. With massive weight loss, many patients may utilize body contouring for deformities. After massive weight loss following bariatric surgery, patients often develop significant nutritional deficiencies that increase the risk of postoperative morbidity and mortality with any subsequent surgeries. Some unique patients will require additional evaluation during illness or when considering elective surgery due to alterations to the alimentary tract, in order to optimize outcomes and prevent complications from nutritional deficiencies.
Assuntos
Humanos , História do Século XXI , Complicações Pós-Operatórias , Obesidade Mórbida , Relatos de Casos , Literatura de Revisão como Assunto , Redução de Peso , Morbidade , Mortalidade , Estudo de Avaliação , Deficiências Nutricionais , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Cirurgia Bariátrica , Ciências da Nutrição , Obesidade/patologia , Complicações Pós-Operatórias/mortalidade , Obesidade Mórbida/cirurgia , Obesidade Mórbida/patologia , Deficiências Nutricionais/cirurgia , Deficiências Nutricionais/patologia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/cirurgia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/patologia , Cirurgia Bariátrica/efeitos adversos , Cirurgia Bariátrica/métodos , Ciências da Nutrição/métodos , Obesidade , Obesidade/cirurgiaRESUMO
Rhizomelic chondrodysplasia punctata (RCDP) is a group of disorders with overlapping clinical features including rhizomelia, chondrodysplasia punctata, coronal clefts, cervical dysplasia, congenital cataracts, profound postnatal growth retardation, severe intellectual disability, and seizures. Mutations in PEX7, GNPAT, and AGPS, all involved in the plasmalogen-biosynthesis pathway, have been described in individuals with RCDP. Here, we report the identification of mutations in another gene in plasmalogen biosynthesis, fatty acyl-CoA reductase 1 (FAR1), in two families affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity. Exome analyses revealed a homozygous in-frame indel mutation (c.495_507delinsT [p.Glu165_Pro169delinsAsp]) in two siblings from a consanguineous family and compound-heterozygous mutations (c.[787C>T];[1094A>G], p.[Arg263(∗)];[Asp365Gly]) in a third unrelated individual. FAR1 reduces fatty acids to their respective fatty alcohols for the plasmalogen-biosynthesis pathway. To assess the pathogenicity of the identified mutations, we transfected human embryonic kidney 293 cells with plasmids encoding FAR1 with either wild-type or mutated constructs and extracted the lipids from the cells. We screened the lipids with gas chromatography and mass spectrometry and found that all three mutations abolished the reductase activity of FAR1, given that no fatty alcohols could be detected. We also observed reduced plasmalogens in red blood cells in one individual to a range similar to that seen in individuals with RCDP, further supporting abolished FAR1 activity. We thus expand the spectrum of clinical features associated with defects in plasmalogen biosynthesis to include FAR1 deficiency as a cause of syndromic severe intellectual disability with cataracts, epilepsy, and growth retardation but without rhizomelia.
Assuntos
Anormalidades Múltiplas/genética , Aldeído Oxirredutases/deficiência , Catarata/genética , Deficiências Nutricionais/genética , Epilepsia/genética , Deficiência Intelectual/genética , Modelos Moleculares , Aldeído Oxirredutases/química , Aldeído Oxirredutases/genética , Sequência de Bases , Cromatografia Gasosa , Deficiências Nutricionais/patologia , Feminino , Genótipo , Células HEK293 , Humanos , Mutação INDEL/genética , Lipídeos/análise , Imageamento por Ressonância Magnética , Masculino , Espectrometria de Massas , Dados de Sequência Molecular , Linhagem , Análise de Sequência de DNA , SíndromeRESUMO
BACKGROUND: Roux-en-Y gastric bypass (RYGB) is considered the gold standard for the treatment of morbid obesity. There is no consensus over ideal limb length when the bypass is created and published studies do not take into account the influence of the common limb (CL) on weight loss. The objective was to study the influence of the common limb after RYGB. The setting was the Virgen de la Arrixaca University Clinical Hospital in Murcia, Spain. MATERIAL AND METHODS: This prospective study includes 151 patients undergoing laparoscopic RYGB surgery for morbid obesity. The patients were divided into 2 groups according to their body mass index. The small intestine (SI) was measured using micro forceps so that the percentage of common limb (%CL) could then be compared against the total SI in each patient. The percentage of excess weight loss (%EWL) in relation to the %CL was calculated at 3, 12, and 24 months. A series of tests was conducted simultaneously to analyze nutritional deficiencies and their relation to the %CL. RESULTS: The total jejunoileal segment and the %CL in the groups of both obese and super-obese patients had no influence on the %EWL in either group for any of the periods studied. The patients with a %CL<50% had greater nutritional deficiencies in the follow-up period and required supplements and more frequent laboratory tests. CONCLUSIONS: The %CL has no effect on weight loss in RYGB patients. A lower %CL is related to greater nutritional deficiencies.